Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL9 | O00512 | 1/20 | 0.81 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.81 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.57 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.57 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | MGLL | Q99685 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3091851 | 0.93 | BCL9 (0.71) | BCL9CTNNB1GAAPTPN7PTPN12 | |
| SCHEMBL3919600 | 0.93 | BCL9 (0.76) | BCL9CTNNB1GAAPTPN7PTPN12 | |
| SCHEMBL531007 | 0.93 | BCL9 (0.76) | BCL9CTNNB1GAAPTPN7PTPN12 | |
| SCHEMBL27557226 | 0.92 | BCL9 (0.74) | BCL9CTNNB1GAAPTPN7PTPN12 | |
| SCHEMBL13701877 | 0.92 | BCL9 (0.69) | BCL9CTNNB1GAAPTPN7PTPN12 | |
| SCHEMBL570540 | 0.91 | BCL9 (0.73) | BCL9CTNNB1GAAPTPN7PTPN12 | |
| SCHEMBL2607873 | 0.91 | BCL9 (0.73) | BCL9CTNNB1GAAPTPN7PTPN12 | |
| SCHEMBL530771 | 0.91 | BCL9 (0.73) | BCL9CTNNB1GAAPTPN7PTPN12 | |
| SCHEMBL7079988 | 0.91 | BCL9 (0.73) | BCL9CTNNB1GAAPTPN7PTPN12 | |
| SCHEMBL531155 | 0.91 | BCL9 (0.73) | BCL9CTNNB1GAAPTPN7PTPN12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3474890-B1 | PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION | MAX PLANCK GESELLSCHAFT (DE) | 2026-05-06 | — | — | EP | disclosed |
| EP-4729073-A1 | SYNTHETIC VACCINES AGAINST FRANCISELLA TULARENSIS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-04-22 | — | — | EP | disclosed |
| EP-4682154-A1 | PROTECTED TETRASACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF OLIGOSACCHARIDES REPRESENTING SEGMENTS OF O-ANTIGENS FROM DIVERSE SHIGELLA FLEXNERI SEROTYPES | Institut Pasteur (FR) | 2026-01-21 | — | — | EP | disclosed |
| WO-2025215228-A1 | SYNTHETIC VACCINES AGAINST PORPHYROMONAS GINGIVALIS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2025-10-16 | — | — | WO | disclosed |
| EP-4631951-A1 | SYNTHETIC VACCINES AGAINST PORPHYROMONAS GINGIVALIS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2025-10-15 | — | — | EP | disclosed |
| US-12043643-B2 | Vaccine against klebsiella pneumoniae | IDORSIA PHARMACEUTICALS LTD (CH) | 2024-07-23 | — | — | US | disclosed |
| CN-111448205-B | Vaccine against klebsiella pneumoniae | 爱杜西亚药品有限公司 | 2024-05-14 | — | — | CN | disclosed |
| WO-2024028192-A1 | USE OF CONJUGATES OF HUMAN SERUM ALBUMIN AND PHOSPHOCHOLINE FOR BLOCKING C-REACTIVE PROTEIN | PENTRACOR GMBH (DE) | 2024-02-08 | — | — | WO | disclosed |
| US-20240024489-A1 | PROTECTED DISACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF ZWITTERIONIC OLIGOSACCHARIDES, AND CONJUGATES THEREOF | INSTITUT PASTEUR (FR) | 2024-01-25 | — | — | US | disclosed |
| US-11850309-B2 | Cationic materials and formulations for drug delivery | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2023-12-26 | — | — | US | disclosed |
| WO-1992022583-A2 | TRI- AND TETRA-VALENT MONOSPECIFIC ANTIGEN-BINDING PROTEINS | CELLTECH LIMITED (GB) | 1992-12-23 | — | — | WO | disclosed |
| EP-0457438-A2 | Conjugate compounds containing aza-macrocycles, and processes for their preparation | CELLTECH THERAPEUTICS LIMITED (GB) | 1991-11-21 | — | — | EP | disclosed |
| WO-1991016078-A1 | CONJUGATE COMPOUNDS CONTAINING AZA-MACROCYCLES, AND PROCESSES FOR THEIR PREPARATION | CELLTECH LIMITED (GB) | 1991-10-31 | — | — | WO | disclosed |
| WO-1991000285-A1 | TRI-AZA MACROCYCLES AND PROCESSES FOR THEIR PREPARATION | CELLTECH LIMITED (GB) | 1991-01-10 | — | — | WO | disclosed |
| EP-0404605-A2 | Tri-aza macrocycles and processes for their production | CELLTECH THERAPEUTICS LIMITED (GB) | 1990-12-27 | — | — | EP | disclosed |
| US-4883864-A | COUPLED AND FREE AMINE GROUPS CAPPED WITH UREA OR AMIDE GROUPS, EYE SURGERY | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-11-28 | — | — | US | disclosed |
| US-4851513-A | Viscoelastic collagen solution for opthalmic use and method of preparation | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-07-25 | — | — | US | disclosed |
| US-4713446-A | COLLAGEN COUPLED TO CARBONYL OR SULFONYL GROUPS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1987-12-15 | — | — | US | disclosed |
| EP-0214853-A2 | Viscoelastic collagen solution for ophthalmic use and method of preparation | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1987-03-18 | — | — | EP | disclosed |
| US-4181661-A | SCHIZOPHRENIA, PSYCHOLOGICAL DISORDERS | MERCK & CO., INC. (US) | 1980-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240024489-A1 | PROTECTED DISACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF ZWITTERIONIC OLIGOSACCHARIDES, AND CONJUGATES THEREOF | SI, DAD1, FUT5 | BCL9 3994/4885CTNNB1 3389/4885GAA 613/4885 |
| US-11850309-B2 | Cationic materials and formulations for drug delivery | SLC7A1, SLC43A1, AADAT | BCL9 3485/4885CTNNB1 2544/4885GAA 1750/4885 |
| US-12043643-B2 | Vaccine against klebsiella pneumoniae | SLC11A2, OSTC, STT3A | BCL9 3206/4885CTNNB1 4394/4885GAA 911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.